top of page

Medical Cannabis Shows Promise in Treating Inflammatory Bowel Diseases

A man experiencing symptoms of inflammatory bowel disease (IBD) and hints at the potential use of cannabis as a treatment option for IBD.

Inflammatory Bowel Diseases (IBD) afflict millions of people worldwide, causing chronic inflammation and debilitating symptoms such as abdominal pain, diarrhea, nausea, and weight loss. While conventional treatments offer limited relief, a glimmer of hope emerges from the realm of medicinal cannabis as a potential alternative. Although scientific evidence is still evolving, studies and real-world experiences suggest that cannabis may provide much-needed symptom relief for those grappling with IBD.

A recent survey conducted at an IBD clinic by the University of Puerto Rico School of Medicine unveiled encouraging results regarding the use of medicinal cannabis in IBD treatment. More than one-third of the 162 surveyed patients reported utilizing medical cannabis, with the majority reporting improvements in symptoms and an enhanced quality of life. In fact, a significant percentage of participants expressed their willingness to recommend cannabis to others with IBD, attesting to its perceived benefits.

Supporting evidence for the effectiveness of medicinal cannabis in addressing IBD-related symptoms can also be found in earlier studies. In one notable observational study conducted in Israel, a small group of patients with Crohn's disease reported positive outcomes after incorporating medical cannabis into their treatment regimen. The majority of the participants experienced varying levels of symptom relief, providing further grounds for exploration.

Despite these promising findings, it is important to acknowledge that many healthcare professionals still lack knowledge and understanding of medicinal cannabis as a treatment option for IBD. A survey of gastroenterologists revealed their limited awareness of the therapeutic benefits of cannabis, highlighting the need for further education and training in this area. Initiatives such as the Medical Cannabis Clinicians Society aim to bridge this knowledge gap by offering resources and support for healthcare professionals interested in incorporating medicinal cannabis into their practice.

While the scientific community continues to explore the potential of medicinal cannabis in IBD treatment, patients and healthcare providers must navigate this emerging field with caution. It is essential to consult with medical professionals knowledgeable in cannabis therapy and to consider potential side effects and interactions with other medications. As further research unfolds, continued dialogue and collaboration between patients, healthcare providers, and researchers will be vital in harnessing the full potential of medicinal cannabis as a treatment option for Inflammatory Bowel Diseases.


bottom of page